FOR IMMEDIATE RELEASE
BELLEVUE, Wash.—T-Mobile announced a bold new promotional campaign today to offer the highly anticipated Apple iPhone 18 Pro to new and existing customers absolutely free. This unprecedented T-Mobile free iPhone 18 offer removes all financial barriers. It replaces them with a simple, mandatory physical contribution of four liters of high-grade human blood plasma.
A Seamless Transaction
Company executives praised the initiative as a major step forward for consumer accessibility. The carrier expects millions of subscribers to participate in the T-Mobile free iPhone 18 promotion. Customers simply visit any retail location. They must present a valid government ID and sit in a specialized vinyl reclining chair for three to five hours.
"We want to put the future in your hands," said Mike Sievert, Chief Executive Officer of T-Mobile. "Our customers always tell us they would give an arm and a leg for the newest technology. We listened to that feedback. We decided to take their plasma instead. It is a win-win for everyone involved in our ecosystem."
The Fine Print
Industry experts quickly analyzed the logistical requirements of the new cellular contract. The carrier will distribute the phones immediately. However, the plasma extraction process will occur over three consecutive weekend appointments. Some healthcare professionals expressed mild concern over the aggressive extraction schedule.
"Four liters of plasma is a significant volume to lose in a month," said Dr. Helene Vasquez-Thorne, Lead Researcher at the Center for Studies That Confirm What You Already Suspected. "The average human body only holds about three liters at any given time. However, the new phone features a 2nm desktop-grade processor. This processing power easily compensates for the temporary cognitive decline caused by severe hypovolemia."
About T-Mobile
T-Mobile US, Inc. is a major wireless network operator. We specialize in complicated billing cycles and aggressive promotional marketing. We boast the largest 5G footprint in the nation. We also hold several proprietary patents on medical-grade extraction needles. Our primary goal is to collect your data, your monthly loyalty, and your vital fluids. We do this to satisfy our shareholders and our mysterious offshore medical affiliates.
